Jörg Trappe

1.3k total citations
15 papers, 831 citations indexed

About

Jörg Trappe is a scholar working on Molecular Biology, Oncology and Clinical Biochemistry. According to data from OpenAlex, Jörg Trappe has authored 15 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Clinical Biochemistry. Recurrent topics in Jörg Trappe's work include Mitochondrial Function and Pathology (3 papers), Metabolism and Genetic Disorders (3 papers) and Peptidase Inhibition and Analysis (3 papers). Jörg Trappe is often cited by papers focused on Mitochondrial Function and Pathology (3 papers), Metabolism and Genetic Disorders (3 papers) and Peptidase Inhibition and Analysis (3 papers). Jörg Trappe collaborates with scholars based in Switzerland, Germany and United States. Jörg Trappe's co-authors include Doriano Fabbro, Peter Seibel, Sergio Papa, Peter Drueckes, Pascal Furet, Heinz Reichmann, Thomas Klopstock, Gaetano Villani, Jürgen Mestan and Gabriele Fendrich and has published in prestigious journals such as Nucleic Acids Research, Journal of Molecular Biology and Journal of Medicinal Chemistry.

In The Last Decade

Jörg Trappe

15 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jörg Trappe Switzerland	14	463	180	153	105	81	15	831
Giang T. Le Australia	14	537 1.2×	108 0.6×	249 1.6×	113 1.1×	59 0.7×	18	825
Joseph W. Leone United States	17	888 1.9×	267 1.5×	134 0.9×	104 1.0×	61 0.8×	38	1.5k
Michelle L. Kraus United States	7	466 1.0×	447 2.5×	96 0.6×	145 1.4×	68 0.8×	9	1.1k
Jakob Fuhrmann United States	20	947 2.0×	219 1.2×	123 0.8×	58 0.6×	41 0.5×	27	1.4k
Joseph Rahuel Switzerland	18	896 1.9×	236 1.3×	269 1.8×	188 1.8×	42 0.5×	24	1.4k
Zoltán Greff Hungary	13	1.0k 2.2×	312 1.7×	225 1.5×	70 0.7×	73 0.9×	21	1.5k
Amaury E. Fernández‐Montalván Germany	19	1.0k 2.2×	185 1.0×	86 0.6×	137 1.3×	32 0.4×	38	1.3k
Robert L. Tansik United States	13	385 0.8×	87 0.5×	220 1.4×	135 1.3×	50 0.6×	19	849
Françoise Perron‐Sierra France	14	517 1.1×	135 0.8×	156 1.0×	41 0.4×	25 0.3×	22	925
Yantao He United States	22	1.2k 2.5×	283 1.6×	322 2.1×	32 0.3×	97 1.2×	42	1.9k

Countries citing papers authored by Jörg Trappe

Since Specialization

Citations

This map shows the geographic impact of Jörg Trappe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Trappe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Trappe more than expected).

Fields of papers citing papers by Jörg Trappe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Trappe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Trappe. The network helps show where Jörg Trappe may publish in the future.

Co-authorship network of co-authors of Jörg Trappe

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Trappe. A scholar is included among the top collaborators of Jörg Trappe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Trappe. Jörg Trappe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Trappe, Jörg, et al.. (2019). A high‐throughput screening for inhibitors of riboflavin synthase identifies novel antimicrobial compounds to treat brucellosis. FEBS Journal. 286(13). 2522–2535. 18 indexed citations

Fairhurst, Robin A., Thomas Knoepfel, Catherine Leblanc, et al.. (2017). Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region. MedChemComm. 8(8). 1604–1613. 31 indexed citations

Namoto, Kenji, Finton Sirockin, Nils Ostermann, et al.. (2014). Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV. Bioorganic & Medicinal Chemistry Letters. 24(3). 731–736. 15 indexed citations

Günther, Marcel, Silke M. Bauer, Eva Döring, et al.. (2014). Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases. Journal of Medicinal Chemistry. 58(1). 443–456. 43 indexed citations

Fedorov, O., K. Huber, Andreas Eisenreich, et al.. (2011). Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing. Chemistry & Biology. 18(1). 67–76. 163 indexed citations

Huber, K., Laurent Brault, O. Fedorov, et al.. (2011). 7,8-Dichloro-1-oxo-β-carbolines as a Versatile Scaffold for the Development of Potent and Selective Kinase Inhibitors with Unusual Binding Modes. Journal of Medicinal Chemistry. 55(1). 403–413. 62 indexed citations

Gerspacher, Marc, Pascal Furet, Carole Pissot‐Soldermann, et al.. (2010). 2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1724–1727. 21 indexed citations

Liniger, Marc, Christian Neuhaus, Peter Drueckes, et al.. (2010). Kinase Inhibition by Deoxy Analogues of the Resorcylic Lactone L-783277. ACS Medicinal Chemistry Letters. 2(1). 22–27. 24 indexed citations

Manley, Paul W., Peter Drueckes, Gabriele Fendrich, et al.. (2009). Extended kinase profile and properties of the protein kinase inhibitor nilotinib. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1804(3). 445–453. 179 indexed citations

10.

Burkey, B F, et al.. (2008). Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited. Diabetes Obesity and Metabolism. 10(11). 1057–1061. 86 indexed citations

11.

Ostermann, Nils, Bernd Gerhartz, Susanne Worpenberg, Jörg Trappe, & Jörg Eder. (2004). Crystal Structure of an Activation Intermediate of Cathepsin E. Journal of Molecular Biology. 342(3). 889–899. 26 indexed citations

12.

Weber, Olaf, Wolfgang Bender, Siegfried Goldmann, et al.. (2001). Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo. Antiviral Research. 49(3). 179–189. 27 indexed citations

13.

Papa, Sergio, et al.. (1996). Mitochondrial diseases and aging. Molecular Aspects of Medicine. 17(6). 511–563. 17 indexed citations

14.

Seibel, Peter & Jörg Trappe. (1996). Eine gentherapeutische Strategie zur Behandlung von Energiestoffwechsel‐Erkrankungen. Chemie in unserer Zeit. 30(5). 235–243. 2 indexed citations

15.

Seibel, Peter, Jörg Trappe, Gaetano Villani, et al.. (1995). Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Research. 23(1). 10–17. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact